Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2006 Prescribing Placebos Perry G. Fine, MD Virtual Mentor. 2006;8(6):377-380. doi: 10.1001/virtualmentor.2006.8.6.ccas4-0606. In the Literature Oct 2004 Some Ethical Concerns about Placebo Operations Luke P. Brewster, MD Virtual Mentor. 2004;6(10):443-445. doi: 10.1001/virtualmentor.2004.6.10.jdsc1-0410. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605. In the Literature Jul 2001 Clinical Use of Placebo Keith Bauer, PhD, MSW Virtual Mentor. 2001;3(7):226-227. doi: 10.1001/virtualmentor.2001.3.7.jdsc1-0107. Case and Commentary Feb 2013 Profiling Patients to Identify Prospective Donors Richard E. Thompson, MD If wealth screening and patient care must be mixed, they would be safer and more effective if guided by a policy developed with input from physicians. Virtual Mentor. 2013;15(2):114-118. doi: 10.1001/virtualmentor.2013.15.2.ecas3-1302. Case and Commentary Nov 2010 The Ethics of Diagnosing Nonepileptic Seizures with Placebo Infusion James L. Bernat, MD Virtual Mentor. 2010;12(11):854-859. doi: 10.1001/virtualmentor.2010.12.11.ccas3-1011 AMA Code Says Nov 2010 AMA Code of Medical Ethics’ Opinions on Using Drugs and Surgery for Purposes Other than Treatment AMA Council on Ethical and Judicial Affairs Virtual Mentor. 2010;12(11):860-863. doi: 10.1001/virtualmentor.2010.12.11.coet1-1011. Case and Commentary Oct 2010 Infective Endocarditis in the Intravenous Drug User James N. Kirkpatrick, MD Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets. Virtual Mentor. 2010;12(10):778-781. doi: 10.1001/virtualmentor.2010.12.10.ccas1-1010.
Case and Commentary Jun 2006 Prescribing Placebos Perry G. Fine, MD Virtual Mentor. 2006;8(6):377-380. doi: 10.1001/virtualmentor.2006.8.6.ccas4-0606.
In the Literature Oct 2004 Some Ethical Concerns about Placebo Operations Luke P. Brewster, MD Virtual Mentor. 2004;6(10):443-445. doi: 10.1001/virtualmentor.2004.6.10.jdsc1-0410.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605.
In the Literature Jul 2001 Clinical Use of Placebo Keith Bauer, PhD, MSW Virtual Mentor. 2001;3(7):226-227. doi: 10.1001/virtualmentor.2001.3.7.jdsc1-0107.
Case and Commentary Feb 2013 Profiling Patients to Identify Prospective Donors Richard E. Thompson, MD If wealth screening and patient care must be mixed, they would be safer and more effective if guided by a policy developed with input from physicians. Virtual Mentor. 2013;15(2):114-118. doi: 10.1001/virtualmentor.2013.15.2.ecas3-1302.
Case and Commentary Nov 2010 The Ethics of Diagnosing Nonepileptic Seizures with Placebo Infusion James L. Bernat, MD Virtual Mentor. 2010;12(11):854-859. doi: 10.1001/virtualmentor.2010.12.11.ccas3-1011
AMA Code Says Nov 2010 AMA Code of Medical Ethics’ Opinions on Using Drugs and Surgery for Purposes Other than Treatment AMA Council on Ethical and Judicial Affairs Virtual Mentor. 2010;12(11):860-863. doi: 10.1001/virtualmentor.2010.12.11.coet1-1011.
Case and Commentary Oct 2010 Infective Endocarditis in the Intravenous Drug User James N. Kirkpatrick, MD Patients who use drugs intravenously may be at high risk for relapse, but their situation is no more futile than that of persons with diabetes and coronary artery disease who smoke and frequent all-you-can-eat buffets. Virtual Mentor. 2010;12(10):778-781. doi: 10.1001/virtualmentor.2010.12.10.ccas1-1010.